Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of…
Alto Neuroscience reported results from its Phase 2a study of ALTO-100, demonstrating clear evidence of efficacy and favorable safety in patients with…